Taiwan Liposome Company, Ltd. Unsponsored ADR Operating Income 2019-2021 | TLC
Taiwan Liposome Company, Ltd. Unsponsored ADR operating income from 2019 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Taiwan Liposome Company, Ltd. Unsponsored ADR Annual Operating Income (Millions of US $) |
|
|---|---|
| 2020 | $-35 |
| 2019 | $-27 |
| 2018 | $-29 |
| 2017 | $-30 |
| Taiwan Liposome Company, Ltd. Unsponsored ADR Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2021-06-30 | $-3 |
| 2021-03-31 | $-8 |
| 2020-12-31 | $-12 |
| 2020-09-30 | $-8 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-7 |
| 2019-12-31 | $-10 |
| 2019-09-30 | $-6 |
| 2019-06-30 | $-8 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $-9 |
| 2018-09-30 | $-6 |
| 2018-06-30 | $-8 |
| 2018-03-31 | $-6 |
